Comparing clinician knowledge and online information regarding Alli (Orlistat).
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 19716762.
- Also identified by DOI 10.1016/j.ijmedinf.2009.07.003 and PMC identifier 2757524.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Many consumers join online communities focused on health. Online forums are a popular medium for the exchange of health information between consumers, so it is important to determine the accuracy and completeness of information posted to online forums. We compared the accuracy and completeness of information regarding the FDA-approved over-the counter weight-loss drug Alli (Orlistat) from forums and from clinicians. We identified Alli-related questions posted on online forums and then posed the questions to 11 primary care providers. We then compared the clinicians' answers to the answers given on the forums. A panel of blinded experts evaluated the accuracy and completeness of the answers on a scale of 0-4. Another panel of blinded experts categorized questions as being best answered based on clinical experience versus review of the literature. The accuracy and completeness of clinician responses was slightly better than forum responses, but there was no significant difference (2.3 vs. 2.1, p=0.5). Only one forum answer contained information that could potentially cause harm if the advice was followed. Forum answers were comparable to clinicians' answers with respect to accuracy and completeness, but answers from both sources were unsatisfactory.
Medical subject headings
- Consumer Health Information
- Drug Information Services
- Evidence-Based Medicine
- Health Knowledge, Attitudes, Practice
- Lactones
- Obesity